What’s New

Article Dec 20, 2024
Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv

Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or…

Interview Dec 4, 2024
Spatial Transcriptomics Expertise: An Interview With Dr. Wendy Teft

Wendy Teft, PhD, Vice President of Precision Medicine and Head of AcelaBio AcelaBio, Alimentiv’s state-of-the-art specialty laboratory, specializes in delivering high-quality histopathology and precision medicine…

Article Aug 2, 2023
Why aren’t more Clinical Trials using Adaptive Designs?

If adaptive designs can bring strong advantages to clinical trials, then why does their adoption remain low?  Clinical trials typically follow a fixed design, where…

Article Jun 30, 2023
What is the Difference between Biostatistics and Statistics?

In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often…

News Jun 26, 2023
Alimentiv Inc. launches Alimentiv Statistics

London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the…

Article Apr 18, 2023
Pharmacokinetics vs Pharmacodynamics: Understanding their role in Drug Discovery

Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how…

Article Mar 21, 2023
A Practical Look at Sample Size Re-Estimation of the Promising Zone Design

The randomized controlled clinical trial (RCT) with a fixed design has become a gold standard for evaluating drug safety and efficacy since its debut. However,…

News Mar 20, 2023
Celebrating our Women: Part Two

Continuing with our celebration during Women’s History Month and for International Women’s day, we are proud to profile two more of the incredible women that…